Evidence map›Paper›PMID 34608212›Full record

ArticleScientific reports2021

Leu-to-Phe substitution at prM

Takuya Inagaki, Satoshi Taniguchi, Yasuhiro Kawai, Takahiro Maeki, Eri Nakayama, Shigeru Tajima, Haruko Takeyama, Chang Kweng Lim, Masayuki Saijo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Takuya InagakiDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Satoshi TaniguchiDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Yasuhiro KawaiDivision of Biosafety Control and Research, Management Department of Biosafety and Laboratory Animal, National Institute of Infectious Diseases, Tokyo, Japan.
Takahiro MaekiDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Eri NakayamaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Shigeru TajimaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Haruko TakeyamaDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
Chang Kweng LimDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan. ck@nih.go.jp.
Masayuki SaijoDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan. msaijo@nih.go.jp.
National Institute of Infectious Diseases · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus (ZIKV) is a mosquito-borne flavivirus that causes febrile illness. The recent spread of ZIKV from Asia to the Americas via the Pacific region has revealed unprecedented features of ZIKV, including transplacental congenital infection causing microcephaly. Amino acid changes have been hypothesized to underlie the spread and novel features of American ZIKV strains; however, the relationship between genetic changes and the epidemic remains controversial. A comparison of the characteristics of a Southeast Asian strain (NIID123) and an American strain (PRVABC59) revealed that the latter had a higher replication ability in cultured cells and higher virulence in mice. In this study, we aimed to identify the genetic region of ZIKV responsible for these different characteristics using reverse genetics. A chimeric NIID123 strain in which the E protein was replaced with that of PRVABC59 showed a lower growth ability than the recombinant wild-type strain. Adaptation of the chimeric NIID123 to Vero cells induced a Phe-to-Leu amino acid substitution at position 146 of the prM protein; PRVABC59 also has Leu at this position. Leu at this position was found to be responsible for the viral replication ability and partially, for the pathogenicity in mouse testes.

Indexed as

Amino Acid SubstitutionHost-Pathogen InteractionsMutationAnimalsChlorocebus aethiopsDisease Models, AnimalGenome, ViralGenomicsMiceVero CellsViral Envelope ProteinsVirulenceVirus ReplicationZika VirusZika Virus InfectionprM protein, FlavivirusViral Envelope Proteins

Identifiers

PMID34608212
PMCPMC8490429
OpenAlexW3202737636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.